Cite
MLA Citation
James W. Smithy et al.. “Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma.” Journal for immunotherapy of cancer, vol. 5, no. 1, 2017, p. . http://access.bl.uk/ark:/81055/vdc_100137791479.0x000002